The U.S. health system is recognized as the world’s leader in clinical innovation, yet millions of Americans do not have health insurance, reducing their access to those life-enhancing and life-saving treatments. AEI has invited twenty academic experts from around the country as well as members of the Washington health policy community to discuss those issues. The first session takes a hard look at what the federal government can do to promote health insurance coverage for all Americans. The second session addresses how Food and Drug Administration regulation affects medical progress. Mark McClellan, newly-appointed commissioner of the Food and Drug Administration, will give the luncheon address and will discuss the administration’s health policies.